Keywords: Liver, Liver, HCC, MTM-HCC
Motivation: Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma (MTM-HCC) has been confirmed to possess higher invasiveness and malignancy.
Goal(s): This study aims to compare the clinical parameters and imaging characteristics between MTM-HCC and non-MTM-HCC patients, construct a predictive model for the MTM-HCC subtype, and evaluate the model's value in risk stratification.
Approach: This study is a retrospective research.
Results: The ≥ 50% AP hypovascular component and peritumoral hypointensity on HBP images are independent predictive factors for diagnosing MTM-HCC, and the predictive model exhibits a significant difference in overall recurrence-free survival (RFS) and early recurrence (P < 0.05).
Impact: This study, based on the significant imaging features of LI-RADS v2018 and other imaging signs, offers clinical value for the diagnosis and prognosis prediction of the MTM-HCC pathological subtype, providing new insights for the personalized treatment of HCC patients.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords